AzTrials
AzTrials

Product Use IssueNCT04181580

Feasibility Study Focusing on Fit of Made-to-measure Compression Garments in Healthy Subjects

A study testing Made-to-measure compression garment in people with Product Use Issue, run by BSN Medical GmbH at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Fit of made-to-measure compression garments in healthy subjects will be tested on one day, simulating daily activities. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Product Use Issue
What is being tested?
Made-to-measure compression garment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteGermany
Study dates
28 Nov 2019to 13 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Men, women or diverse
  • Full legal competence
  • Age between 18 and 70 years
  • Capability to understand the subject information and to provide conscious informed consent
  • All female or diverse subjects of childbearing potential must either be surgically sterile (hysterectomy or tubal ligation) or agree to use a reliable method of contraception with a Pearl-Index of less than 1% per year when used consistently and correctly such as implants, injectables, combined oral contraceptives, some intra uterine devices (IUDs), sexual abstinence or vasectomized partner for at least 4 weeks
  • Willingness to conduct a urine pregnancy test for all females or potentially childbearing diverse subjects
Show all 9Show fewer
  • Capability and willingness to follow protocol requirements
  • Signed informed consent for study participation and data protection regulations
  • Body mass index (BMI) >23 kg/m² and ≤ 40 kg/m²

Who cannot join

  • Circumference of the largest circumference of the upper leg >80 cm (measured in the upright position)
  • Shape distortions
  • Diagnosed lymphedema of the upper and/or lower extremities
  • Diagnosed lipedema of upper and/or lower extremities
  • Diagnosed indication for therapy with flat-knitted compression garments
  • Alcohol abuse as reported by subject and/ or suspected by investigator
Show all 41Show fewer
  • Drug abuse as reported by subject and/ or suspected by investigator
  • Allergy or sensitivity to one or more components of the investigational devices, as far as reported by the subject
  • Circumference of the largest circumference of the upper leg >80 cm (measured in the upright position)
  • Shape distortions
  • Diagnosed lymphedema of the upper and/or lower extremities
  • Diagnosed lipedema of upper and/or lower extremities
  • Diagnosed indication for therapy with flat-knitted compression garments
  • Alcohol abuse as reported by subject and/ or suspected by investigator
  • Drug abuse as reported by subject and/ or suspected by investigator
  • Allergy or sensitivity to one or more components of the investigational devices, as far as reported by the subject
  • Pregnancy or breastfeeding
  • Diagnosed peripheral arterial disease
  • Presence of untreated phlebitis, or septic phlebitis
  • Diagnosed progressed arterial insufficiency including ischemia
  • Diagnosed congestive heart failure
  • Diagnosed clinically relevant hypertension
  • Diagnosed renal insufficiency or kidney failure
  • Presence of Untreated or progressing skin infection
  • Presence of large coagulum in the leg vein
  • Presence of phlegmasia coerulea dolens
  • Diagnosed Raynaud's disease
  • Diagnosed gonarthrosis
  • Diagnosed ankle arthrosis
  • Diagnosed rheumatoid arthritis
  • Presence of Exuding dermatoses
  • Presence of gangrene
  • Diagnosed malign lymphedema
  • Diagnosed psoriasis
  • Diagnosed diabetes mellitus
  • Diagnosed complex regional pain syndrome (CRPS; Sudeck atrophy)
  • Diagnosed polyneuropathy
  • Diagnosed severe impaired skin sensitivity und impaired sensitivity of the extremities, including all sensory malfunctions and diagnosed impaired pain sensitivity
  • Objections of the investigator to the subject's participation in the trial due to medical reasons or any other reason for which the subject should not participate in the opinion of the investigator
  • Participation in any clinical investigation with systemic and/or pharmaceutical substances within the last 4 weeks and/or in parallel
  • Sponsors, manufacturers or CRO staff

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • bioskin GmbH

    Hamburg, 20095

Other trials in Germany

About this study

Official title: Explorative, Monocentric, Feasibility Study Focusing on Fit of Innovative, Made-to-measure Compression Garments in Healthy Subjects

Fit of made-to-measure compression garments in healthy subjects will be tested on one day, simulating daily activities.

Read the detailed description

Lower and upper extremities of 36 health subjects will be measured be trained experts to collect measures for made-to-measure compression garments.

Fit of made-to-measure compression garments, which are not on the market yet, among healthy subjects will be tested on one day, simulating daily activities. Fit will be assessed directly after donning and after a wearing period of maximum 7 hours at the study site by trained experts. Healthy subjects will give back study products at the end of the wearing period. AEs will be documented throughout the study.

Being tested
Made-to-measure compression garment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Made-to-measure compression garmentDevice

    Made-to-measure compression garment

Study groups in NCT04181580
Study groupRoleWhat they receive
Fit test of made-to-measure garmentsOtherHealthy subjects will test maximum 2 compression garments out of 6 garments under investigation
Receives: Device: Made-to-measure compression garment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the fit of the investigational device

    Evaluation of the fit of the investigational medical device at the end of a wearing period of approximately 4 - 7 hours by predefined criteria, to be worn by healthy subjects once.

    Measured: One day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2019
  2. Study start28 Nov 2019
  3. Primary completion13 Dec 2019
  4. Study completion13 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Healthy subjects will test made-to-measure compression garments. No comparator group due to exploartive design
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04181580
Sponsor's protocol ID
BSN-C2593
Status last verified
Jan 2020
First submitted
26 Nov 2019
Last updated
18 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No IPD will be shared. Data are needed for confidential medical device development.

Questions about this trial

What is this clinical trial studying?

A study testing Made-to-measure compression garment in people with Product Use Issue, run by BSN Medical GmbH at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 41 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the fit of the investigational device (time frame: One day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in